HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Industry Roundup: Children's Rhinocort, MusclePharm Restructuring

This article was originally published in The Tan Sheet

Executive Summary

Senators stir bulk caffeine criticism; AHPA updates membership process; Weiss heads Nutrition 21; and more news in brief.

You may also be interested in...



Nonprescription Nasonex Gains UK Regulator’s Support

The UK MHRA is accepting comments on its recommendation to allow pharmacy sales of nonprescription Nasonex Allergy Control (mometasone furoate/100 mcg).

Nonprescription Nasonex Gains UK Regulator’s Support

The UK MHRA is accepting comments on its recommendation to allow pharmacy sales of nonprescription Nasonex Allergy Control (mometasone furoate/100 mcg).

AHPA Comments On Vinpocetine: Health And Wellness Industry News Roundup

AHPA argues FDA erred in vinpocetine proposal; and MusclePharm CEO bails out firm again.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS108885

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel